Cited by 97Cytomegalovirus and herpesvirus researchViral-associated cancers and disordersHerpesvirus Infections and Treatments

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation

Open access
Bhanushali, Minal J., Kranick, Sarah M., Freeman, Alexandra F., Cuellar-Rodriguez, Jennifer M., Battiwalla, Minoo, Gea-Banacloche, Juan C., Hickstein, Dennis D., Pavletic, Steven +2 more·2013·Neurology

Abstract

OBJECTIVE: To describe the presentation and management of encephalitis due to human herpes 6 virus (HHV-6) in patients who underwent allogeneic hematopoietic stem cell transplant (alloHSCT), via retrospective chart review. METHODS: Of the 243 patients who underwent alloHSCT at the NIH Clinical Center during 2009 to 2011, we retrospectively analyzed 9 diagnosed with HHV-6 encephalitis post-alloHSCT. RESULTS: Eight men and 1 woman (aged 19-60 years) met diagnostic criteria for study inclusion. The median time from HSCT to initial symptoms was 21 days. All patients presented with altered mental status and headaches. Seven patients had amnesia and 2 presented with fever of unknown etiology. Four patients had clinical seizures during the disease course. Brain MRI within 7 days was normal in all patients. Repeat MRI after 7 days showed hyperintensity in the limbic area in 3 patients. On initial testing, CSF analysis indicated acellularity and normal or minimally elevated protein; presence of HHV-6 was detected by PCR. After 7 days, mildly elevated protein and minimal pleocytosis were noted. Ganciclovir, foscarnet, or valganciclovir alone or in combination was initiated with subsequent improvement. Four patients remained alive at 1 year posttransplant; 2 had persistent memory deficits. Presence of encephalitis was associated with higher mortality post-alloHSCT. CONCLUSION: High clinical suspicion and CSF PCR testing are important for early diagnosis of HHV-6 encephalitis post-HSCT. Abnormalities on brain MRI or CSF testing may be minimal and delayed. Diagnosis and management of HHV-6 encephalitis is challenging, and a larger prospective study is needed for further research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0b013e31828cf8a2

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both paediatric patients were diagnosed with primary HHV-6 infection.

    “Both paediatric patients were diagnosed with primary HHV-6 infection.”

    From Human Herpesvirus 6—A Rare Aetiologic Agent for CNS Infections in Immunocompetent Individuals or an Underestimation? (2024) · cites this paper as [14]

    The Results report that all nine patients with HHV-6 encephalitis were aged 19–60 years, so the study had no paediatric patients. The Abstract describes HHV-6 reactivation after stem cell transplantation, not a diagnosis of primary infection in two children. (LLM, conf=0.90)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bhanushali, M. J., Kranick, S. M., Freeman, A. F., Cuellar-Rodriguez, J. M., Battiwalla, M., Gea-Banacloche, J. C., Hickstein, D. D., Pavletic, S., Fahle, G., & Nath, A.
Affiliations
  • National Institutes of Health (US)
  • From the National Institute of Neurological Disorders and Stroke (NINDS) (M.J.B., S.M.K., A.N.); National Institute of Allergy and Infectious Diseases (NIAID) (A.F.F., J.M.C.-R.); National Institute of Heart, Lung and Blood Institute (NHLBI) (M.B.); National Cancer Institute (NCI) (J.C.G.-B., D.D.H., S.P.), Experimental Transplantation and Immunology Branch; and Department of Laboratory Medicine (G.F.), National Institutes of Health, Bethesda, MD.
Venue
Neurology
Published
2013-04-16
Volume
80
Issue
16
Pages
1494-1500
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W2022000054
Cited by
97
References
16
Citations by year
2026: 4 · 2025: 6 · 2024: 8 · 2023: 2 · 2022: 6 · 2021: 8 · 2020: 4 · 2019: 7 · 2018: 8 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 6 · 2013: 4
FWCI
8.03
Type
journal article
Language
en
Open access
Locations
  • Neurology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • National Cancer Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Neurological Disorders and Stroke
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
Keywords
HHV-6 encephalitis, allogeneic hematopoietic stem cell transplantation, herpesvirus infection, central nervous system infection, ganciclovir, foscarnet, valganciclovir, cerebrospinal fluid PCR, memory impairment, post-transplant mortality, opportunistic infections
MeSH terms
Adult, Aged, Antiviral Agents, Brain, Female, Follow-Up Studies, Headache, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Prognosis, Retrospective Studies, Seizures, Survival, Herpesvirus 6, Human, Hematopoietic Stem Cell Transplantation, Disease Progression, Hematologic Neoplasms, Roseolovirus Infections, Viral Load, Young Adult, Neuroimaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review